M ultiple sclerosis (MS) is a chronic and debilitating immune-mediated disease affecting the central nervous system, whose clinical course, with its almost uncountable associated symptoms, presents as a challenge for the treating staff team 1 . Fatigue is the most disabling symptom of MS, affecting 75-90% of patients and can be defined as "a subjective lack of physical or mental energy that is perceived by the individual or caregiver to interfere with usual and desired activities" 2,3 . In a nutshell, fatigue has at least three dimensions: (1) physical, characterized by reduced motor performance at daily tasks; (2) cognitive, characterized by deterioration of time response, alertness and concentration; and (3) social, characterized by behavior of avoiding to meet people and to take part in outdoor events 4 . Fatigue in MS is not provoked by one single but by many causes concurrently. The main factors associated with fatigue in MS are MS itself (demyelination and axonal loss, also known as "primary fatigue"), complications related to MS (pain, cognitive impairment, spasticity, gait disorders, among others), medications, depression and sleep problems 5 . The presence of so many factors involved in the pathogenesis and/or exacerbation of fatigue in patients with MS makes it extremely hard to be quantified, which is almost always done incompletely.
. Interestingly, patients with MS suffering from obstructive sleep apnea complain more about fatigue than overt EDS. On the other hand, Veauthier et al. 12 did not find correlation between PSG findings and poor sleep quality in MS patients but did show a corrlation with depression, as measured by Beck Depression Inventory. Cognitive impairment can be detected in 40% to 70% of patients with MS and the interaction of fatigue and cognitive disturbances is well established, although the exact mechanism remains unclear 13 . Finally, patients with SPMS without evidence of inflammatory activity represent a huge therapeutic challenge and more detailed information about sleep quality in this specific population could help clinicians to better manage their patients 14 . Braga et al. add a contribution in the study of MS and its comorbidities, as they report that patients with RRMS who experienced sleepiness and fatigue (63.1%) suffered from moderate to severe depression (p = 0.001), strengthening the relationship among fatigue, EDS and depression in patients with RRMS and also reinforcing the high frequency of fatigue and its association with EDS in patients with MS.
From a practical point of view, the take-home messages that can be extracted from the article are: (1) Inquire about the quality of sleep of your MS patients; (2) diagnose and treat depression when present. One should keep in mind that fatigue and sleep quality can improve significantly when depression is treated 15 .
